BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 3, 2020
View Archived Issues
Bayer presents data from the phase II FOXTROT study of osocimab
Read More
First-in-human data for NEO-201 in chemoresistant solid tumors
Read More
NHP model of Ebola virus infection via mucosal challenge
Read More
CureVac and CEPI collaborate to develop vaccine against coronavirus nCoV-2019
Read More
Follicum receives grant to study binding of FOL peptides to pancreatic cell receptors
Read More
Promising results presented for leronlimab in patients with breast cancer
Read More
Vaccitech presents data from the FLU009 phase II study of its VTP-100 vaccine
Read More
Adapting NGS for coronavirus surveillance
Read More
Long QT genes mostly short on evidence
Read More
Immunotherapy combination shows promise in NSCLC
Read More
Preclinical data lead to clinical study of in derazantinib in advanced gastric cancer
Read More
Exelixis presents phase Ib data for XL-888 plus pembrolizumab in advanced gastrointestinal cancer
Read More
Voronoi patents new protein kinase inhibitors
Read More
GlaxoSmithKline discloses CREB2 inhibitors
Read More
Gilead Sciences describes new IRAK-4 inhibitors
Read More
Rodin Therapeutics divulges HDAC inhibitors
Read More
Eli Lilly and Company presents SERD inducers for cancer
Read More
DB-020 prevents cisplatin-induced hearing loss in animal model, enters clinical trial
Read More
Calibr begins first-in-human study of CCW-702 in metastatic castration-resistant prostate cancer
Read More
Eisai initiates phase II study of E-7090 in advanced cholangiocarcinoma with FGFR2 gene fusion
Read More
Researchers develop an animal model of Marburg virus infection
Read More
Gilead provides remdesivir for use in response to novel coronavirus
Read More
FDA approves Palforzia oral immunotherapy for peanut allergy
Read More
Corvus offers new data from ongoing phase I/Ib trial of CPI-818 in advanced T-cell lymphomas
Read More